For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Lifeedit Therapeutics, Inc.

USPTO Granted Patents = 18

EPO Patents = 3

Trademarks = 2

Forward Citations = 4

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Tedd D Elich (18 out of 28 patents)

Alexandra Briner Crawley (18 out of 21 patents)

Tyson D Bowen (15 out of 15 patents)

4. Michael Coyle (11 out of 11 patents)

5. Rodolphe Barrangou (4 out of 37 patents)

6. Joel S Parker (3 out of 7 patents)

7. Gunjan H Arya (3 out of 3 patents)

8. Mark R Moore (2 out of 47 patents)

9. Michael W Lassner (2 out of 69 patents)

18 patents: Sort by Forward Citations

1. 12680096 - RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (2026-07-14),

2. 12655426 - Polypeptides useful for gene editing and methods of use (2026-06-16),

3. 12624369 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2026-05-12),

4. 12473539 - RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (2025-11-18),

5. 12435325 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-10-07),

6. 12398385 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-08-26),

7. 12398384 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-08-26),

8. 12338455 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-06-24),

9. 12252718 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-03-18),

10. 12252706 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2025-03-18),

11. 12188062 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2025-01-07),

12. 12188061 - Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the same (2025-01-07),

13. 12188018 - Polypeptides useful for gene editing and methods of use (2025-01-07),

14. 11981940 - DNA modifying enzymes and active fragments and variants thereof and methods of use (2024-05-14),

15. 11981916 - RNA-guided nucleases and active fragments and variants thereof and methods of use (2024-05-14),

Company Overview

Lifeedit Therapeutics, Inc. is a biotechnology company based in Research Triangle Park, North Carolina, specializing in gene editing technologies. The organization focuses on developing innovative solutions for genetic disorders and therapeutic applications, leveraging advanced CRISPR-based systems. Lifeedit aims to transform the landscape of genetic medicine by providing precise and efficient tools for genome editing, ultimately enhancing treatment options for various diseases and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

18 Patents

#23 in Research Triangle Park, NC

#395 in North Carolina

#17,952 in US

#34,187 in the World

Research Triangle Park, NC, United States of America

Lifeedit Therapeutics, Inc.

Forward Citations = 4

9 inventors:

Tedd D Elich (18 out of 28 patents)

Alexandra Briner Crawley (18 out of 21 patents)

Tyson D Bowen (15 out of 15 patents)

4. Michael Coyle (11 out of 11 patents)

5. Rodolphe Barrangou (4 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lifeedit Therapeutics, Inc.. Retrieved from https://idiyas.com/company/lifeedit-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…